Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Vor Biopharma
Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjögren’s Disease
May 19, 2026
Vor Bio Announces $75 Million Private Placement with TCGX
May 19, 2026
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2026
←
Previous Page
1
2